Pfizer said its Covid-19 vaccine blocked 94% of asymptomatic infections in an Israeli study – a result CEO Albert Bourla called “extremely important.”
Business, Tech, Energy, Transportation
Pfizer said its Covid-19 vaccine blocked 94% of asymptomatic infections in an Israeli study – a result CEO Albert Bourla called “extremely important.”